Trials / Completed
CompletedNCT01274000
A Study to Evaluate Efficacy of YM060 on Diarrhea-predominant Irritable Bowel Syndrome (D-IBS) in Female Patients
Phase II Study of YM060 - Double-blind, Parallel-group Comparative Study in Patients (Female) With Diarrhea-predominant Irritable Bowel Syndrome
- Status
- Completed
- Phase
- Phase 2
- Study type
- Interventional
- Enrollment
- 409 (actual)
- Sponsor
- Astellas Pharma Inc · Industry
- Sex
- Female
- Age
- 20 Years – 64 Years
- Healthy volunteers
- Not accepted
Summary
A study to verify the superiority of YM060 (ramosetron) to placebo for female patients with diarrhea-predominant irritable bowel syndrome (D-IBS) and to evaluate its safety.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | YM060 | oral |
| DRUG | placebo | oral |
Timeline
- Start date
- 2010-11-01
- Primary completion
- 2011-10-01
- Completion
- 2011-10-01
- First posted
- 2011-01-11
- Last updated
- 2015-10-12
Locations
4 sites across 1 country: Japan
Source: ClinicalTrials.gov record NCT01274000. Inclusion in this directory is not an endorsement.